However, we recently identified silibinin, the main bioactive compound of thistle extract, as an in vitro pancreatic lipase inhibitor, which suggested a potential role as an anti-obesity agent. The gene discussed is PNLIP; the disease is obesity due to melanocortin 4 receptor deficiency.